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Abstract
Background: Paroxysmal atrial tachyarrhythmias frequently occur in beta-thalassemia major 
(β-TM) patients.The aim of our study was to investigate the role of maximum P-wave duration 
(P max) and dispersion (PD), calculated trough a new manually performed measurement with 
the use of computer software from all 12-ECG-leads,as predictors of atrial-fibrillation (AF)in 
β-TM patients with conserved systolic or diastolic cardiac function during a twelve-months 
follow-up.
Materials and Methods: 50 β-TM-patients (age38.4±10.1; 38M) and 50-healthy subjects used 
as controls, matched for age and gender, were studied for the occurrence of atrial arrhythmias 
during a 1-year follow-up, through ECG-Holter-monitoring performed every three months. 
The β-TM-patients  were divided into two groups according to number  and complexity  of 
premature-supraventricular-complexes  at  the  Holter-Monitoring  (Group1:  <30/h  and  no 
repetitive forms, n:35; Group2: >30/h or couplets, or run of supraventricular tachycardia and 
AF,  n:15).                                              
Results: Compared to the healthy control-group, β-TM patients presented increased P-max 
(107.5± 21.2 vs 92.1±11ms, P=0.03) and PD-values (41.2±13 vs 25.1±5 ms,P=0.03). In the β-
TM population,  the Group2 showed a statistically  significant  increase in PD (42.8±8.6 vs 
33.2±6.5ms,  P<0.001)  and  P-max  (118.1±8.7  vs  103.1±7.5ms,  P<0.001)  compared  to  the 
Group1. Seven β-TM patients who showed paroxysmal AF during this study had significantly 
increased P-max and PD than the other patients of the Group2. Moreover, P-max (OR:2.01; 
CI:1.12-3.59;  P=0.01)  and  PD (OR=2.06;CI:1.17-3.64;P=0.01)  demonstrated  a  statistically 
significant association with the occurrence of paroxysmal AF,P min was not associated with 
AF-risk (OR=0.99; CI:0.25-3.40; P=0.9) in β-TM-patients. A cut-off value of 111ms for P-
max had a sensitivity of 80% and a specificity of 87%, a cut-off value of 35.5ms for PD had a 
sensitivity  of  90% and a  specificity  of  85% in  identifying  β-TM patients  at  risk  for  AF.
Conclusion: Our results indicate that P-max and PD are  useful  electrocardiographic  markers 
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for identifying the β-TM-high-risk patients for AF onset, even when the cardiac function is 
conserved.
                        
Key words: beta-thalassemia major, P-wave dispersion, atrial fibrillation                    
Introduction
Beta-Thalassemia  Major  (β-TM)  is  a  hereditary  haemoglobin  disorder  caused  by  reduced 
synthesis of β-globin chain and resulting in a chronic haemolytic anaemia. The consequences 
of  chronic  anaemia  include  growth  retardation,  bone  marrow  expansion,  extramedullary 
hematopoiesis, splenomegaly, greater intestinal iron absorption, hypercoagulability and higher 
susceptibility  to  infections  [1].  In  the  early  stage,  patients  are  usually  asymptomatic. 
Restrictive cardiomyopathy usually occurs before dilated cardiomyopathy [2], in accordance 
with diastolic dysfunction which normally happens before systolic dysfunction and overt heart 
failure [3-5]. Findings in the early stage are usually incidental, including bradycardia, ST-T 
changes, infrequent premature atrial or ventricular contractions, first-degree atrioventricular 
blocks and evidence of left ventricular hypertrophy. In the late stage, frequent premature atrial 
or ventricular contractions, runs of supraventricular tachycardia, atrial flutter and fibrillation, 
ventricular tachycardia and second-degree or complete heart blocks have been demonstrated 
[2,5,6].  
QTc and JTc dispersion are useful electrocardiographic markers of sudden cardiac death risk 
and  are  increased  in  some  conditions  [7-12].  Our  previous  study  suggested  that  beta 
thalassemia  major  is  associated  with  significant  changes  in  heterogeneity  of  ventricular 
repolarization,  the electrophysiological substrate for ventricular malignant tachyarrhythmias, 
and the use of QTc dispersion and JTc dispersion, as simple electrocardiographic parameters 
for stratifying the sudden cardiac death risk in beta thalassemia  major  patients,  should be 
implemented in our daily clinical practice [13].                                             
The identification of β-TM patients at risk for atrial fibrillation is of pivotal importance for the 
optimization  of  the  medical  therapy  to  prevent  tromboembolic  stroke.  Maximum P  wave 
duration (P max) and P wave dispersion (PD) are two simple electrocardiographic markers 
considered to reflect the discontinuous and inhomogeneous propagation of sinus impulses and 
the prolongation of atrial conduction time [14,15]. PD was shown to be an independent risk 
factor for development of atrial fibrillation [16,17]. In a previous study [18], we showed a 
significant increase of P wave dispersion, correlated to myocardial iron deposit, assessed by 
Cardiac Magnetic Resonance (CMR) T2 imaging, in β-TM patients with conserved systolic 
and diastolic cardiac function. However, to our knowledge, there are no studies evaluating the 
predictive value of PD and P max on new onset AF occurrence in β-TM patients.         
The aim of the present study was to determine whether maximum P-wave duration and P-
wave  dispersion  detected  on  surface  ECG could  predict  the  new onset  paroxysmal  atrial 
fibrillation  occurrence  in  β-TM  patients  with  conserved  systolic  and  diastolic  cardiac 
function.
Materials  and  Methods                                                 
Study  population                                                         
The study involved 50 β-TM subjects (38 men, 12 women), with a mean age of 38.4 ± 10.1 
years and mean body mass index (BMI) of 20.1 ± 3.1 kg/m2. All patients were consecutively 
recruited from the Internal Medicine of Cardarelli  Hospital  to participate  in the study and 
followed for a 12 months period. Fifty sex and age-matched non β-TM healthy subjects were 
also recruited as controls. Inclusion criteria were age between 18 and 50 years. Subjects with a 
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history  of  hypertension  (systolic  and  diastolic  blood  pressure  >  140/90  mmHg),  diabetes 
mellitus or impaired glucose tolerance (IGT), obesity,  electrolyte imbalance,  valvular heart 
disease, heart failure, coronary artery disease, systolic and diastolic dysfunction, connective 
tissue  disorders,  left  bundle  branch  block  or  atrioventricular  conduction  abnormalities  on 
electrocardiogram  (ECG),  previous  AF  episodes,  hepatic,  renal,  thyroid  diseases,  sleep 
disorders, or having a permanent pacemaker were excluded from the study. All patients were 
in  sinus  rhythm,  and  none  of  them  was  taking  medications  known  to  affect 
electrocardiographic  intervals  (antiarrhythmic  agents,  tricyclic  antidepressants, 
antihistaminics, or antipsychotics). All patients were requiring regular blood transfusions at 2-
4 weekly intervals to maintain haemoglobin levels over 9 g/dl. The patients were receiving 
iron chelation therapy either  as standard desferrioxamine (DFO) 40-50 mg/kg sc 5 days a 
week or as deferiprone (DFP), which was given at a daily dose of 75 mg/kg either as a single  
agent  or  in  combination  with  DFO  (40-50  mg/kg  twice  weekly).           
Study  protocol                                        
Medical history, physical examination, anthropometric evaluation, 12-lead surface ECG, ECG 
Holter  monitoring  and  2D  color  doppler  echocardiogram  were  performed  in  the  study 
population.  The cardiac evaluation was standardized to blood transfusion interval  and was 
performed at a median of 5 days (ranged 1-8) following transfusions and every three months 
during  the  12  months  follow  up.  The  patients  were  rested  for  at  least  15  min  before 
cardiovascular assessments, including electrocardiography and echocardiography. All patients 
gave  their  informed  consent.                                   
Electrocardiographic  measurements                                 
All subjects underwent a routine standard 12-lead body surface ECG recorded at a paper speed 
of 50 mm/s and gain of 10 mm/mV in the supine position and were breathing freely but not 
allowed  to  speak  during  the  ECG  recording.  To  avoid  diurnal  variations,  we  generally 
evaluated  the  ECG  recordings  at  the  same  time  (9:00-10:00  A.M.).  The  analysis  was 
performed by one investigator only without knowledge of subject's clinic status. ECGs were 
transferred  to  a  personal  computer  by an optical  scanner  and then magnified  to  400% by 
Adobe  Photoshop  software  (Adobe  Systems  Inc.,  San  Jose,  CA).  P-wave  duration 
measurement  was  manually  performed  with  the  use  of  computer  software  (Configurable 
Measurement System) from all 12 ECG leads. These new PD measurement method allowed us 
to minimize measurement errors done with manual evaluation that may be a potential bias for 
observed  results  and  to  overcome  the  limitations  of  the  measurement  of  a  useful 
electrocardiographic parameter as PD, the validity of which has been much debated in the 
literature. Intra-observer coefficients of variation for P wave variables were found to be less 
than  5% and  not  significant.  In  each  electrocardiogram  lead,  the  analysis  included  three 
consecutive heart cycles wherever possible. ECG with measurable P-wave in less than ten-
leads were excluded from analysis. The onset of P wave was defined as the junction between 
the isoelectric line and the start of P-wave deflection; the offset of the P-wave as the junction 
between the end of the P-wave deflection and the isoelectric line [19,20]. If starting points and 
endpoints  were  not  clear,  the  derivations  including  these  points  were  taken  as  excluding 
criteria from the study. Maximum and minimum P-wave durations were measured. Maximum 
P-wave duration was defined as the longest P-wave duration, and minimum P-wave duration 
was defined as the shortest P-wave duration. P-wave dispersion was defined as the difference 
between  the  maximum P-wave  duration  and the  minimum P-wave duration.             
Echocardiographic  measurements                                 
Images were gathered with a standard ultrasound machine with a 3.5-MHz phased-array probe 
(M3S). All the echocardiographic studies were digitally stored and all the measurements were 
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performed off-line by two independent observers who were blinded to the clinical status of the 
subjects.  Left  ventricular  (LV)  diameter  and  wall  thickness  were  measured  from the  two 
dimensional  targeted  M-mode  echocardiographic  tracings  in  the  parasternal  short  axis. 
Ejection  fraction  was  measured  using  a  modified  Simpson's  biplane  method.  Each 
representative value was obtained from the average of three measurements.  LV mass was 
determined and indexed to height (meters) to the power of 2.7 (LVM/H 2.7). Pulsed-wave 
Doppler examination was performed to obtain the following indexes of LV diastolic function: 
peak mitral inflow velocities at early (E) and late (A) diastole and E/A ratio. Average values 
of  these  indexes  obtained  from  5  consecutive  cardiac  cycles  were  used  for  analysis.
Holter  recording                                    
Seven  leads  24h  ECG  Holter  recording  was  performed  using  a  commercially  available 
equipment (Cardioscan Holter System, DMS, Stateline NV, USA) every three months during 
the 12 months follow up period. The β-TM patients were divided into two groups according to 
number and complexity of supraventricular arrhythmias at the Holter Monitoring: Group 1: 
<30/h premature supraventicular complexes (PSCs) and no repetitive forms (n: 35 patients); 
Group  2:  >30/h  premature  supraventicular  complexes  or  supraventricular  couplets  or 
supraventricular tachycardia and atrial fibrillation (n: 15 patients). All healthy control subjects 
underwent 24 h ECG Holter monitoring every three months during the observation period and 
they did not show atrial  or ventricular arrhythmias (they presented less than 10 premature 
supraventricular  or ventricular  complexes during 24 hours at the ECG Holter Monitoring).
Statistical  Analysis                                      
Continuous variables were expressed as mean values ± standard deviation (SD). Statistical 
analysis was performed using Student's t-test. Multivariable analysis with a Cox proportional 
hazards model was used to test whether the occurrence of paroxysmal AF was related to age, 
gender, PD and P max. A receiver-operating characteristics (ROC) curve was constructed to 
identify the P wave cutoff values that differentiate patients with and without occurrence of 
paroxysmal AF with the best sensitivity and specificity levels. In all statistical tests, calculated 
P  values  of  less  than  0.05  were  considered  statistically  significant.  Correlations  were 
performed  using  Spearman's  correlation  analysis.  Statistical  comparisons  were  performed 
using  the  statistical  software  package  SPSS 10.01  (SPSS Inc.,  Chicago,  IL,  USA).      
Results
Clinical  and  echocardiographic  parameters                                        
Table 1 summarizes the clinical, laboratory and echocardiographic characteristics of the study 
population. Healthy control group did not significantly differ from β-TM group in BMI, heart 
rate,  blood  pressure  (BP)  and  atrial  diameters  and  areas.  The  β-TM  group  showed 
significantly higher left ventricular posterior wall end diastolic thickness (LVPWEDT: 9.1 ± 
0.4 vs 6.7 ± 1.8 mm;  P = 0.04), inter- ventricular septum end diastolic diameter thickness 
(IVSEDT: 9.3  ±  0.9  vs  6.1  ±  1.1  mm;  P  =  0.04),  left  ventricular  end diastolic  diameter 
(LVEDD: 53.8 ± 4.9 vs 42.2 ± 3.1 mm;  P = 0.04),  left  ventricular  end systolic  diameter 
(LVESD: 33.5 ± 5.6 vs 25.3 ± 2.6 mm; P = 0.04). However, no significant difference in left  
ventricle fractional shortening (FS: 31.8 ± 4.1 vs 33.8 ± 3.9 %;  P = 0.3) and ejection fraction 
(EF: 64.3 ± 7.9 vs 65.1 ± 4.9 %; P = 0.2) between the two groups were observed. These data 
indicate compensated normal systolic function in the β-TM group. Compared with controls, 
the β-TM group did not show significantly E wave (81.8 ± 16.4 vs 91.3 ± 10.6 cm/s; P = 0.3),  
A wave (58.8 ± 13.1 vs 51.1 ± 8.9 cm/s; P = 0.2) and E/A ratio (1.4 ± 0.5 vs 1.6 ± 0.4; P = 0.2) 
variations. These data indicate normal diastolic function in the β-TM group. 
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Table 1: Clinical, laboratory and echocardiographic characteristics of the study population. 
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; EF: ejection  
fraction; SF: shortening fraction; LVEDD: left ventricular end diastolic diameter; LVESD: left ventricular end 
systolic diameter; IVSEDT: interventricular septal end diastolic diameter; LVPWEDT: left ventricular posterior 
wall  end  diastolic  thickness;  LVM/H:  left  ventricular  mass/height                              
P  wave  duration  and  dispersion                                           
Electrocardiographic characteristics of the study population are shown in Table 2. Compared 
with  healthy  control  group,  thalassemic  patients  presented  increased  maximum  P  wave 
duration (107.5 ± 21.2 vs 92.1 ± 11 ms, P = 0.03) and P-wave dispersion values (41.2 ± 13 vs 
25.1 ± 5 ms, P = 0.003). No statistically significant difference was found in heart rate (76.8 ± 
5.4 vs 75.7 ± 6.3 bpm, P= 0.3), PR interval (148 ± 13 vs 142 ± 8 ms, P= 0.4) and minimum P  
wave duration (68.6 ± 12 vs 66.2 ± 7 ms, P = 0.4).                        
Maximum P-wave duration, P wave dispersion and atrial fibrillation incidence                
In the β-TM population, the Group 2 showed a statistically significant increase in PD (42.8 ± 
8.6 vs  33.2 ± 6.5 ms,  P< 0,001)  and P max (118.1 ± 8.7 vs  103.1 ± 7.5 ms,  P< 0,001) 
compared to the Group 1 (Figure 1). No statistically significant difference was shown in HR 
(77.8 ± 5.3 vs 84.9 ± 4.5 beats/min; P= 0.3), PR interval (159 ± 10 vs 143 ± 8 ms, P=0.4) and 
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P min (72.9 ± 7.1 vs 74.3 ± 3.6 ms, P= 0,16). Seven β-TM patients who showed asymptomatic 
paroxysmal  atrial  fibrillation  (mean  AF  episodes  number:  30.1±  12;  mean  AF  episodes 
duration: 38.4 ± 11 minutes; mean AF episodes heart rate: 110.5 ± 26 bpm) during this study 
had significantly increased P max (119.7 ± 8.3 vs 105.1 ± 7.6 ms, P < 0.001) and PD (45.1 ± 
8.4 vs 35.2 ± 6.5 ms, P < 0.001) than the other members of the Group 2. A cut off value of 111 
ms for P max had a sensitivity of 80% and a specificity of 87% in identifying β-TM patients at 
risk for atrial fibrillation, with a positive predictive value of 50% and a negative predictive 
value of 96%. A cut off value of 35.5 ms for PD had a sensitivity of 90% and a specificity of  
85% in identifying this category of patients, with a positive predictive value of 50% and a 
negative predictive value of 98%. The incidence of AF was 2% (1/50) among patients with P 
wave dispersion ≤ 30 ms, 4% (2/50) in patients with P wave dispersion > 30 and ≤ 35.5 ms, 
and 8% (4/50) in patients with P wave dispersion more than 35.5 ms.  P min did not achieve 
statistical significance in multivariable logistic model (OR = 0.99; CI: 0.25-3.40; P = 0.9), 
whereas P max (OR:2.01; CI:1.12-3.59; P = 0.01) and PD (OR = 2.06; CI: 1.17-3.64; P = 
0.01) were significantly associated with AF risk. However, using the multivariable analysis, 
only PD ≥ 35.5 ms (P= 0.04) remained significant as independent predictor of occurrence of 
AF in the study population (Table 3).
Table 2: Electrocardiographic characteristics of the study population. 
   HR: heart rate; PR: atrioventricular interval
Figure 1: P wave dispersion (PD) and maximum P wave duration (P max) in the two groups of β-TM patients  
separated according to the ECG Holter monitoring results (Group 1: <30/h and no repetitive forms, n: 35; Group 
2:  >30/h  or  couplets,  or  run  of  supraventricular  tachycardia  and  atrial  fibrillation,  n:  15).          
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Table  3:  Results  at  multivariable  analysis  of  P-wave  characteristics  and  multivariable 
predictor  of  occurrence  of  AF in β-TM patients                                       
Association  between  AF  and  age  or  gender                                 
In the multivariable logistic regression model, younger age was associated with a higher AF 
risk, but this trend was not statistically significant (OR = 1.21; CI: 0.53-2.72; P = 0.6). As 
regard gender, males showed a greater AF risk with respect to females, but also in this case 
statistical  significance  was  not  reached  (OR  =  2.27;  CI:  0.26-18.96;  p  =  0.4).
Discussion
Heart  complications  represent  the  leading  cause  of  mortality  in  thalassemia  major,  even 
though,  following  the  introduction  of  chelating  therapies,  an  important  and  progressive 
increase of life expectancy has been demonstrated [21]. While iron-induced cardiomyopathy is 
slowly progressive and it usually takes several decades for clinical or laboratory features of 
cardiac  dysfunction  to  manifest,  atrial  fibrillation  may  be  present  also  if  only  isolated 
myocardial  siderosis,  without  signs  of  cardiac  dysfunction,  is  present.  The  risk  of 
stroke/embolism is increased 5-fold in patients with AF compared to subjects in sinus rhythm. 
The cardio-embolic stroke has been reported in 0.25-0.46% of patients with β-TM in different 
endemic  countries  [22,23].  While  patients  with  sickle  -  β  thalassemia  and  thalassemia 
intermedia present asymptomatic ischaemic lesions that spare the cortex [24,25], patients with 
β-TM  seem  to  suffer  large  hemispheric  territorial  infarcts  in  presence  of  AF  and 
cardiomyopathy [26]. No data are currently available regarding the prophylactic efficacy of 
antiplatelet  or  anticoagulant  drugs  for  prevention  of  thromboembolism  related  to  atrial 
fibrillation in β-TM population, and this now requires dedicated studies. The 12-lead resting 
ECG  remains  the  most  frequently  used  examination  in  the  evaluation  of  patients  for 
cardiovascular disease and, because of its relatively low cost, it has the greatest potential to be 
used  as  a  screening  tool.  The  ECG  ability  to  predict  AF  may  identify  a  group  of  beta 
thalassemia patients whose thromboembolic stroke risk can be modified. To our knowledge, 
there are no studies evaluating the predictive value of PD and P max on AF recurrence in β-
TM patients.  The  aim of  the  present  study  was  to  determine  whether  maximum  P-wave 
duration and P-wave dispersion detected on surface ECG may could predict the new onset 
paroxysmal  atrial  fibrillation  occurrence  in  β-TM  patients  with  conserved  systolic  and 
diastolic  cardiac  function.                                      
P wave dispersion and chronic  anaemia                                             
Little is known in literature about the P wave dispersion in chronic anaemia patients. Simsek 
et al. [27] showed that P max and PD were significantly prolonged in 97 patients with iron 
deficiency  anemia  and  mean  haemoglobin  value  of  7.9±1.6  g/dl;  they  hypothesized  that 
compromised oxygen delivery capacity  due  to  anaemia  may  result  in  chronic  tissue 
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hypoxemia,  which  may then lead  to  myocyte  dysfunction.                              
In our previous study, we investigated the P-wave dispersion in beta thalassemia patients with 
normal  systolic  and  diastolic  function  and  correlated  the  PD  to  myocardial  iron  deposit, 
assessed by CMR T2* imaging. Our data showed a significant increase in P max and PD in β-
TM patients with conserved systolic and diastolic cardiac function, compared to sex and age-
matched  normal  controls,  and suggested  the  hypothesis  that  iron  overload  toxicity  per  se 
influences  earlier  the  propagation  of  sinus  impulses  and  the  atrial  conduction  time  than 
mechanical  cardiac  function  [18].                                           
P  wave  dispersion  and  atrial  fibrillation                                        
P  wave  dispersion  is  a  non  invasive  indicator  of  intra-atrial  conduction  heterogeneity 
producing  substrate  for  reentry,  which  is  one  of  pathophysiological  mechanisms  of  atrial 
fibrillation [28]. PD has been studied in some other conditions  such as hypertension [29], 
obesity [30], diabetes mellitus [31], metabolic syndrome [32], dilated cardiomyopathy [33], 
myocardial  infarction  [34],  atrial  septal  defect  [35],  hypertrophic  cardiomyopathy  [36], 
obstructive sleep apnea [37], Emery Dreifuss muscular dystrophy [38] and Wilson's disease 
[39]. The exact mechanism of PD prolongation in these clinical conditions is not well known, 
but  it  is  thought that  structural  and electrophysiological  changes  in the atrial  myocardium 
caused by elevated plasma volume [40], ventricular diastolic dysfunction [41] and enhanced 
neurohormonal  activation [42], typical  conditions of these deseases,  may contribute to left 
atrial enlargement and electrical instability. Dilaveris et al. [43]. firstly showed that prolonged 
P wave duration and P wave dispersion may be used as predictors of frequently relapsing AF. 
In  a  large  cohort  of  patients,  Perez  et  al.  [44]  confirmed  prior  observations  that  P wave 
duration, P wave dispersion, abnormal P axis and left atrial enlargement were predictive of AF 
and introduced the P wave index, defined as the SD of P-wave duration across the 12 leads, as 
novel  measurement  that  could  better  represent  the  atrial  heterogeneity.  According to  their 
findings, P wave index > 35 was one of the strongest predictors of AF (hazard ratio: 2,7). 
There is no consensus about the cutoff value for PD that separates patients who have a history 
of paroxysmal AF from healthy subjects. Dilaveris et al. identified 40 ms as cutoff value of PD 
to separate patients with paroxysmal AF from controls, while Aytemir et al. [45] used a PD cut 
off value of 32.5 ms in another study, which excluded patients with structural heart disease. 
The differences in the cutoff values between these studies may be due to the different  patients' 
clinical  characteristics  and  measurement  methods  used.                           
Main  Findings                                         
Studying  the  effect  of  beta  thalassemia  major  in  patients  without  systolic  or  diastolic 
dysfunction and without other clinically appreciable cause of heart, hepatic, renal, thyroid and 
metabolic diseases, might have offered the unique clinical opportunity to exclude the influence 
of possible comorbidities on the evaluation of inhomogeneous propagation of sinus impulses 
and  the  relationship  with  the  onset  of  atrial  fibrillation.  Our  data  confirmed  that  the 
electrocardiographic parameters proposed to estimate the discontinuous and inhomogeneous 
propagation of sinus impulses and the prolongation of atrial conduction time (Pmax and PD) 
were  significantly  increased  in  β-TM patients  when compared  with  age  and sex-matched 
healthy  controls.  We showed a  statistically  significant  increase  in  PD and P  max in beta 
thalassemia  major  patients  at  high  risk  for  atrial  fibrillation  onset  and  we  suggested  the 
hypothesis that the abnormal P wave dispersion ≥ 35.5 ms and maximum P wave duration ≥ 
111 ms may predict atrial fibrillation onset in beta thalassemia major patients with conserved 
systolic  and  diastolic  function.                                       
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Limitations
The small number of patients included is certainly a limitation and a more extensive study is 
needed  to  confirm  these  data.  P  wave  dispersion  measurement  errors  done  with  manual 
evaluation may be a potential bias for observed results, although, according to Dilaveris et al. 
[35], scanning and digitizing ECG signals from paper records using an optical scanner is a 
feasible and accurate method for measuring P wave duration. No difference was showed in 
systolic and diastolic function in the study population,  however the β-TM group showed a 
statistically significant difference in ventricle's wall diameter and thickness respect to the sex 
and age-matched healthy control group. These differences indicate that the cardiac structure in 
thalassemia  patients  may not  be  completely  normal,  even when the  systolic  and diastolic 
function  is  preserved.  The  relationship  between  P  wave  dispersion,  cellular  cardiac 
electrophysiological properties and cardiac structural changes are complex and still waiting for 
investigation  on a  larger  study population.                                            
Conclusion
Our study demonstrated that P wave dispersion measurement seems to be a fairly good marker 
for identifying the β-TM high-risk group for atrial fibrillation onset, even when the cardiac 
function  is  conserved.  Our  data  suggest  that  the  use  of  P  wave  dispersion,  as  simple 
electrocardiographic parameter for the atrial fibrillation risk assessment in beta thalassemia 
major patients, should be implemented in our daily clinical practice. PD cut off value ≥ 35.5 
ms and P max cut off value ≥111 ms may identify high risk atrial fibrillation β-TM patients 
who need a careful cardiac monitoring.  For these patients,  we suggest seriate ECG Holter 
recordings  to  early  detect  atrial  fibrillation  onset  and  to  evaluate  the  opportunity  of 
prophylactic  anticoagulation  treatment.                                 
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